These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6431628)

  • 41. [Dexamethasone test and depression].
    Syvälahti E
    Duodecim; 1982; 98(7):535-42. PubMed ID: 7084094
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of the dexamethasone suppression test using DSM-III criteria on an inpatient psychiatric unit.
    Evans DL; Nemeroff CB
    Biol Psychiatry; 1983 Apr; 18(4):505-11. PubMed ID: 6860725
    [No Abstract]   [Full Text] [Related]  

  • 43. The value of DST in unipolar depression.
    Clower CG
    Psychiatr Med; 1984 Dec; 2(4):329-35. PubMed ID: 6599905
    [No Abstract]   [Full Text] [Related]  

  • 44. Interference by carbamazepine with the dexamethasone suppression test.
    Privitera MR; Greden JF; Gardner RW; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1982 May; 17(5):611-20. PubMed ID: 7093397
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of the evolution of some monocytic parameters and neuroendocrine function tests in depressed patients].
    Cervera Enguix S; Rodríguez-Rosado A; Ramos Ruiz F; Sarrais Oteo F; Pla Vidal J; Rodríguez-Rosado R
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(2):67-73. PubMed ID: 7625239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dexamethasone suppression test in depression.
    Thase ME; Neil JF; Horn TL
    Pa Med; 1984 Oct; 87(10):32, 34. PubMed ID: 6542199
    [No Abstract]   [Full Text] [Related]  

  • 47. Four cases of reversion to abnormal dexamethasone suppression test response as indicator of clinical relapse: a preliminary report.
    Holsboer F; Steiger A; Maier W
    Biol Psychiatry; 1983 Aug; 18(8):911-6. PubMed ID: 6615946
    [No Abstract]   [Full Text] [Related]  

  • 48. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
    Brown WA; Haier RJ; Qualls CB
    Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667
    [No Abstract]   [Full Text] [Related]  

  • 49. Biological classification of depressive illness.
    Coppen A; Wood K
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):161S-164S. PubMed ID: 6402001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Value and limits of conducting several neuro-endocrine tests in the diagnosis of depressive states].
    Schmitt L; Granier F; Girard M; Zarouk B; Escande M
    Ann Med Psychol (Paris); 1985 Feb; 143(2):166-74. PubMed ID: 3929664
    [No Abstract]   [Full Text] [Related]  

  • 51. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
    NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
    [No Abstract]   [Full Text] [Related]  

  • 52. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical use of the dexamethasone suppression test].
    De Leo D; Capodieci S
    Minerva Psichiatr; 1984; 25(2):115-25. PubMed ID: 6436632
    [No Abstract]   [Full Text] [Related]  

  • 54. [Nosographic classification of depressive syndromes and neuro-endocrine tests].
    Gay C; Combes A; Benkelfat C; Olié JP; Susini-De Luca H; Kameleddine F; Askienazy S; Lôo H
    Therapie; 1984; 39(3):209-20. PubMed ID: 6431628
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.